Winner Profile
Yu Qiu
CEO, Chongqing Lummy Pharmaceutical
Industry: Pharmaceuticals
Company size: Small
Published: 2016-10-17
Is Chongqing Lummy Pharmaceutical a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Yu Qiu (Chongqing Lummy Pharmaceutical) earned the following Obermatt pins for the management performance.
Obermatt accolades Yu Qiu
| Year | Pin | Category |
|---|---|---|
| 2016 |  |
Operating Performance |
|
Combined Performance | |
| 2015 |  |
Growth Performance |
| 2014 |  |
Investment Performance |
|
Combined Performance | |
|
Operating Performance | |
|
Growth Performance |
Yu Qiu was included in the competition among China Top 100 Growth Companies (China) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.
Performance Overview Yu Qiu
In summary, Yu Qiu obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 69 in Combined Performance indicates that Yu Qiu was better than 69% of all other CEOs that were analyzed as part of the China Top 100 Growth Companies – China for three participations in Obermatt CEO competitions. Yu Qiu’s average ranking can be found in the Multi-Year Rankings for China Top 100 Growth Companies - China.